Warning Letter — swisschlz.com
The FDA Center for Tobacco Products issued a warning letter to swisschlz.com regarding the sale of unauthorized tobacco products through their website.
This action affects the online tobacco retailer swisschlz.com and potentially other online distributors or retailers of nicotine-containing products.
This reflects the Center for Tobacco Products' ongoing monitoring of digital marketplaces. It suggests that companies operating in the online retail space for tobacco or nicotine products must confirm that each product has a valid marketing authorization. Persistent non-compliance with these requirements may lead to further escalated enforcement, such as civil money penalties or permanent injunctions.
Retailers should immediately audit digital storefronts for unauthorized tobacco products and ensure all listings have received required marketing authorization from the FDA. Regulatory teams should assess advertising and labeling for compliance with CTP standards to avoid enforcement action.
FDA Warning Letter issued to: swisschlz.com. 05/01/2026 — Center for Tobacco Products. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/swisschlzcom-729060-05012026
Open in openFDA / FDA.gov